Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Cancer Immunology, Immunotherapy : CII
|
February 23, 2026
Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent
Manasi Nagare, Monalisa Sahoo, Manju Sengar, et al.
International Immunopharmacology
|
June 13, 2023
Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect
Saurabh Kumar Gupta, Dievya Gohil, Deepshikha Dutta, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
January 26, 2023
Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in India
Shasanka Das, Bhausaheb Bagal, Hasmukh Jain, et al.
Journal of Clinical Pathology
|
March 12, 2026
Acute myeloid leukaemia (AML) harbouring <i>KMT2A</i>-PTD: should it be considered as a myelodysplasia-related abnormality?
Narasimhapriyan Kannan, Aarti Achrekar, Vishram Terse, et al.
Hemasphere
|
April 3, 2024
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant
Prashant R Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Transplantation and Cellular Therapy
|
September 7, 2023
Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings
Anant Gokarn, Prashant R Tembhare, Hasan Syed, et al.
JCO Global Oncology
|
February 20, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML
Gojiri Mawalankar, Aarti Achrekar, Seema Biswas, et al.
International Journal of Clinical Practice
|
June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai
Arusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.
Cancer Medicine
|
November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India
Sumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Cancer Medicine
|
October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment
Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Cancer Immunology, Immunotherapy : CII
|
February 23, 2026
Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent
Manasi Nagare, Monalisa Sahoo, Manju Sengar, et al.
International Immunopharmacology
|
June 13, 2023
Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect
Saurabh Kumar Gupta, Dievya Gohil, Deepshikha Dutta, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
January 26, 2023
Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in India
Shasanka Das, Bhausaheb Bagal, Hasmukh Jain, et al.
Journal of Clinical Pathology
|
March 12, 2026
Acute myeloid leukaemia (AML) harbouring <i>KMT2A</i>-PTD: should it be considered as a myelodysplasia-related abnormality?
Narasimhapriyan Kannan, Aarti Achrekar, Vishram Terse, et al.
Hemasphere
|
April 3, 2024
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant
Prashant R Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Transplantation and Cellular Therapy
|
September 7, 2023
Long-Term Cryopreservation of Peripheral Blood Stem Cell Harvest Using Low Concentration (4.35%) Dimethyl Sulfoxide with Methyl Cellulose and Uncontrolled Rate Freezing at -80 °C: An Effective Option in Resource-Limited Settings
Anant Gokarn, Prashant R Tembhare, Hasan Syed, et al.
JCO Global Oncology
|
February 20, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML
Gojiri Mawalankar, Aarti Achrekar, Seema Biswas, et al.
International Journal of Clinical Practice
|
June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai
Arusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.
Cancer Medicine
|
November 17, 2021
Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India
Sumeet P Mirgh, Anant Gokarn, Akhil Rajendra, et al.
Cancer Medicine
|
October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment
Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
Page
of 7